Marathon running increases circulating endothelial- and thrombocyte-derived microparticles

Abstract

Background

Acute vascular effects of high intensity physical activity are incompletely characterized. Circulating microparticles are cellular markers for vascular activation and damage.

Methods

Microparticles were analysed in 99 marathon runners (49 ± 6 years, 22% female) of the prospective Berlin Beat of Running study. Blood samples were taken within three days before, immediately after and within two days after the marathon run. Endothelial-derived microparticles were labelled with CD144, CD31 and CD62E, platelet-derived microparticles with CD62P and CD42b, leukocyte-derived microparticles with CD45 and monocyte-derived microparticles with CD14.

Results

Marathon running induced leukocytosis (5.9 ± 0.1 to 14.8 ± 0.3 10⁹/l, p < 0.0001) and increased platelet counts (239 ± 4.6 to 281 ± 5.9 10⁹/l, p < 0.0001) immediately after the marathon. Blood monocytes increased and lymphocytes decreased after the run (p < 0.0001). Endothelial-derived microparticles were acutely increased (p = 0.008) due to a 23% increase of apoptotic endothelial-derived microparticles (p = 0.007) and returned to baseline within two days after the marathon. Thrombocyte-derived microparticles acutely increased by 38% accompanied by an increase in activated and apoptotic thrombocyte-derived microparticles (p ≤ 0.0001) each. Both monocyte- and leukocyte-derived microparticles were decreased immediately after marathon run (p < 0.0001) and remained below baseline until day 2. Troponin T increased from 12 to 32 ng/l (p < 0.0001) immediately after the run and returned to baseline after two days.

Conclusion

Circulating apoptotic endothelial- and thrombocyte-derived microparticles increased after marathon running consistent with an acute pro-thrombotic and pro-inflammatory state. Exercise-induced vascular damage reflected by microparticles could indicate potential mechanisms of post-exertional cardiovascular complications. Further studies are warranted to investigate microparticles as markers to identify individuals prone to such complications.

Keywords

Microparticles marathon physical activity endothelial dysfunction inflammation

Get full access to this article

View all access options for this article.

References

Running USA. Statistics and research, http://www.runningusa.org/statistics (2015, accessed 13 May 2017).

Schnohr

O’Keefe

Marott

et al.

Dose of jogging and long-term mortality: The Copenhagen City Heart Study. J Am Coll Cardiol 2015; 65: 411–419.

Roberts

Maron

. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 2005; 46: 1373–1374.

Roca

Nescolarde

Lupon

et al.

The dynamics of cardiovascular biomarkers in non-elite marathon runners. J Cardiovasc Transl Res 2017; 10: 206–208.

Jee

Park

et al.

Effect of a prolonged endurance marathon on vascular endothelial and inflammation markers in runners with exercise-induced hypertension. Am J Phys Med Rehabil 2013; 92: 513–522.

Siegel

Stec

Lipinska

et al.

Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol 2001; 88: 918–920, A919.

Mohlenkamp

Lehmann

Breuckmann

et al.

Running: the risk of coronary events: Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008; 29: 1903–1910.

Roh

Rhee

Chaudhari

et al.

The role of exercise in cardiac aging: From physiology to molecular mechanisms. Circ Res 2016; 118: 279–295.

Mause

Weber

. Microparticles: Protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047–1057.

10.

Horstman

Jimenez

et al.

New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 2004; 53: 210–230.

11.

Leroyer

Anfosso

Lacroix

et al.

Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010; 104: 456–463.

12.

Horstman

Ahn

. Platelet microparticles: A wide-angle perspective. Crit Rev Oncol Hematol 1999; 30: 111–142.

13.

Bernal-Mizrachi

Jimenez

et al.

High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962–970.

14.

Boulanger

Amabile

Tedgui

. Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48: 180–186.

15.

Werner

Wassmann

Ahlers

et al.

Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112–116.

16.

Sinning

Losch

Walenta

et al.

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011; 32: 2034–2041.

17.

Tsimerman

Roguin

Bachar

et al.

Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011; 106: 310–321.

18.

Hoyer

Giesen

Nunes Franca

et al.

Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J Cell Mol Med 2012; 16: 2777–2788.

19.

Walenta

Schwarz

Schirmer

et al.

Circulating microparticles as indicators of peripartum cardiomyopathy. Eur Heart J 2012; 33: 1469–1479.

20.

Horstman

Jimenez

et al.

Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118–1135.

21.

Häusler

Endres

. [Study design: Berlin register for medicinal care after cerebral ischAemia in patients with atrial fibrillation]. Dtsch Med Wochenschr 2015; 140(Suppl. 1): S9–S9.

22.

Herm

Topper

Wutzler

et al.

Frequency of exercise-induced ST-T-segment deviations and cardiac arrhythmias in recreational endurance athletes during a marathon race: results of the prospective observational Berlin Beat of Running study. BMJ Open 2017; 7: e015798–e015798.

23.

Schwarz

Bachelier

Schirmer

et al.

Red wine prevents the acute negative vascular effects of smoking. Am J Med 2017; 130: 95–100.

24.

Aengevaeren

Mosterd

Braber

et al.

Relationship between lifelong exercise volume and coronary atherosclerosis in athletes. Circulation 2017; 136: 138–148.

25.

Merghani

Maestrini

Rosmini

et al.

Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation 2017; 136: 126–137.

26.

Lin

DeLuca

et al.

Extreme endurance exercise and progressive coronary artery disease. J Am Coll Cardiol 2017; 70: 293–295.

27.

Thompson

Funk

Carleton

et al.

Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 1982; 247: 2535–2538.

28.

Kim

Malhotra

Chiampas

et al.

Cardiac arrest during long-distance running races. N Engl J Med 2012; 366: 130–140.

29.

Favero

Paganelli

Buffoli

et al.

Endothelium and its alterations in cardiovascular diseases: Life style intervention. Biomed Res Int 2014; 2014: 801896–801896.

30.

Paudel

Panth

Kim

. Circulating endothelial microparticles: A key hallmark of atherosclerosis progression. Scientifica (Cairo) 2016; 2016: 8514056–8514056.

31.

Sossdorf

Otto

Claus

et al.

Cell-derived microparticles promote coagulation after moderate exercise. Med Sci Sports Exerc 2011; 43: 1169–1176.

32.

Lansford

Shill

Dicks

et al.

Effect of acute exercise on circulating angiogenic cell and microparticle populations. Exp Physiol 2016; 101: 155–167.

33.

Boyle

Credeur

Jenkins

et al.

Impact of reduced daily physical activity on conduit artery flow-mediated dilation and circulating endothelial microparticles. J Appl Physiol (1985) 2013; 115: 1519–1525.

34.

Bittencourt

CRO

Izar

MCO

Franca

et al.

Effects of chronic exercise on endothelial progenitor cells and microparticles in professional runners. Arq Bras Cardiol 2017; 108: 212–216.

35.

Laufs

Urhausen

Werner

et al.

Running exercise of different duration and intensity: Effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 2005; 12: 407–414.

36.

Laufs

Werner

Link

et al.

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220–226.

37.

Werner

Furster

Widmann

et al.

Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 2009; 120: 2438–2447.

38.

Werner

Hanhoun

Widmann

et al.

Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol 2008; 52: 470–482.

39.

Bei

et al.

Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury. Basic Res Cardiol 2017; 112: 38–38.

40.

Müller

Dahm

Lorenz

et al.

Changes of intima-media thickness in marathon runners: A mid-term follow-up. Eur J Prev Cardiol 2017; 24: 1336–1342.

41.

Jansen

Yang

Hoelscher

et al.

Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013; 128: 2026–2038.

42.

Todorova

Simoncini

Lacroix

et al.

Extracellular vesicles in angiogenesis. Circ Res 2017; 120: 1658–1673.

43.

Jansen

Nickenig

Werner

. Extracellular vesicles in cardiovascular disease: Potential applications in diagnosis, prognosis, and epidemiology. Circ Res 2017; 120: 1649–1657.

44.

Agouni

Lagrue-Lak-Hal

Ducluzeau

et al.

Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008; 173: 1210–1219.

45.

Bachelier

Biehl

Schwarz

et al.

Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles. PLoS One 2017; 12: e0176311–e0176311.

46.

Liman

Bachelier-Walenta

Neeb

et al.

Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia 2015; 35: 88–94.

47.

Sanz de la Garza

Grazioli

Bijnens

et al.

Inter-individual variability in right ventricle adaptation after an endurance race. Eur J Prev Cardiol 2016; 23: 1114–1124.

48.

Montero

Diaz-Canestro

. Maximal cardiac output in athletes: Influence of age. Eur J Prev Cardiol 2015; 22: 1588–1600.

49.

Pela

Crocamo

Li Calzi

et al.

Sex-related differences in left ventricular structure in early adolescent non-professional athletes. Eur J Prev Cardiol 2016; 23: 777–784.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.29 MB